Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid Hydrodilatation Volume Comparison for Adhesive Capsulitis
NCT05818111Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of triamcinolone acetonide in adhesive capsulitis (AC) (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Visual Analog Scale at 12 weeks. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
adhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT05818111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05818111.